Kelli M Luginbuhl

Title: Kelli M Luginbuhl: Innovator in Biologics Purification

Introduction

Kelli M Luginbuhl is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of biologics purification, holding a total of 8 patents. Her work focuses on developing innovative solutions that enhance the efficiency of biologic capture and purification processes.

Latest Patents

One of her latest patents is titled "Genetically encoded polypeptide for affinity capture and purification of biologics." This invention relates to genetically encoded fusion proteins that consist of a capture component capable of binding a target with high affinity. The fusion proteins also include a peptide polymer, such as elastin-like polypeptides, which exhibit phase behavior suitable for purification. The invention outlines methods for optimizing these capture fusion proteins for specific biologic targets, ensuring that phase separation occurs under favorable conditions, such as at room temperature, lower salt concentrations, and appropriate pH ranges.

Career Highlights

Kelli M Luginbuhl is currently employed at Donaldson Company, Inc., where she continues to advance her research in biologics purification. Her innovative approaches have positioned her as a key figure in her field, contributing to the development of more effective purification methods.

Collaborations

Kelli collaborates with Ashutosh Chilkoti, a fellow researcher, to further enhance the impact of their work in the field of biologics.

Conclusion

Kelli M Luginbuhl's contributions to the field of biologics purification through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the purification of biologics, showcasing the importance of innovation in this critical area of research.